Assessment of response to systemic therapy focusing on metastatic bone disease

Cancer Treatment Reviews

Volumn 27, Issue 3, 2001, Pages 177-180

  Blomqvist, C ^a  

^a Dept of Radiotherapy and Oncology ^*  (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER;

ARTICLE; BONE METASTASIS; BONE RADIOGRAPHY; BONE SCINTISCANNING; CANCER GROWTH; CANCER THERAPY; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DRUG RESPONSE; EVALUATION; HUMAN; MEDICAL DOCUMENTATION; NUCLEAR MAGNETIC RESONANCE IMAGING; RADIOGRAPHY; TECHNIQUE; WORLD HEALTH ORGANIZATION;

EID: 0035013315     PISSN: 03057372     EISSN: None     Source Type: Journal    
DOI: 10.1053/ctrv.2000.0211     Document Type: Article

References (16)

1. Taube T., Beneton M. N., Williams I. L., McCloskey E. V., Kanis J. A. Distinction between focally accelerated bone formation and osteomalacia in carcinoma of prostate metastasised to bone. Br J Urol. 72:1993;98-103.
2. Taube T., Elomaa I., Blomqvist C., Beneton M. N., Kanis J. A. Histomorphometric evidence for osteoclast-mediated bone resorption in metastatic breast cancer. Bone. 15:1994;161-166.
3. Blomqvist C., Elomaa I., Virkkunen P. The response evaluation of bone metastases in mammary carcinoma. The value of radiology, scintigraphy and biochemical markers of bone metabolism. Cancer. 60:1987;2907-2912.
4. Hayward I. L., Carbone P. P., Heusen J. C., Kumaoka S., Segaloff A., Rubens R. D. Assessment of response to therapy in advanced breast cancer. Br J Cancer. 35:1977;292-298.
5. Miller A. B., Hoogstraten B., Staquet M., Winkler A. Reporting results of cancer treatment. Cancer. 47:1981;207-214.
6. Hortobagyi G. N., Libshitz H. I., Seabold J. E. Osseous metastases of breast cancer. Clinical, biochemical, radiographic, and scintigraphic evaluation of response to therapy. Cancer. 53:1984;577-582.
7. Coombes R. C., Dady P., Parsons C. Assessment of response of bone metastases to systemic treatment in patients with breast cancer. Cancer. 52:1983;610-614.
8. Vogel C. L., Schoenfelder J., Shemano I., Hayes D. F., Gains R. A. Worsening bone scan in the evaluation of antitumor response during hormonal therapy of breast cancer. J Clin Oncol. 13:1995;1123-1128.
9. Lokich J. J. Osseous metastases: radiographic monitoring of therapeutic response. Oncology. 35:1978;274-276.
10. Blomqvist C., Risteli L., Risteli J., Virkkunen P., Elomaa I. Markers of type I collagen degradation and synthesis in the monitoring of treatment response in bone metastases from breast carcinoma. Br J Cancer. 73:1996;1074-1079.
11. Vinholes J., Coleman R., Lacombe D. Assessment of bone response to systemic therapy in an EORTC trial: preliminary experience with the use of collagen cross-link excretion. European Organization for Research and Treatment of Cancer. Br J Cancer. 80:1999;221-228.
12. Kiang D. T., Greenberg U., Kennedy B. I. Tumor marker kinetics in the monitoring of breast cancer. Cancer. 65:1990;193-199.
13. Sonoo H., Iurebayashi J. Serum tumor marker kinetics and the clinical course of patients with advanced breast cancer. Surgery Today. 26:1996;250-257.
14. Gold R. I., Seeger U. L., Bassett L. W., Steckel R. J. An integrated approach to the evaluation of metastatic bone disease. Radiologic Clinics of North America. 28:1990;471-483.
15. Yoshida K., Akimoto M. Computed tomographic evaluation of bone metastases in prostatic cancer patients. Advances in Experimental Medicine & Biology. 324:1992;197-204.
16. Vandemark R. M., Shpall E. J., Affronti M. L. Bone metastases from breast cancer: value of CT bone windows. Journal of Computer Assisted Tomography. 16:1992;608-614.